Title:
HETEROCYCLIC COMPOUND
Document Type and Number:
WIPO Patent Application WO/2018/207881
Kind Code:
A1
Abstract:
To provide a compound that can exert a BET family protein-inhibiting effect and is likely to be useful as a prophylactic or therapeutic agent for autoimmune diseases and/or inflammatory diseases (for example, rheumatoid arthritis, multiple sclerosis, idiopathic pulmonary fibrosis, psoriasis, inflammatory bowel disease, Sjogren's syndrome, Bechet's disease and systemic lupus erythematosus), neurodegenerative diseases (for example, Alzheimer's disease), etc. A compound represented by formula (I) [wherein each symbol is as defined in the description] or a salt thereof.
Inventors:
NAKAMURA SHINJI (JP)
HANYA YUKI (JP)
MIKI TAKASHI (JP)
KAMEI TAKU (JP)
HANYA YUKI (JP)
MIKI TAKASHI (JP)
KAMEI TAKU (JP)
Application Number:
PCT/JP2018/018157
Publication Date:
November 15, 2018
Filing Date:
May 10, 2018
Export Citation:
Assignee:
TAKEDA PHARMACEUTICALS CO (JP)
International Classes:
C07D231/14; A61K31/415; A61K31/4155; A61K31/4162; A61K31/4439; A61K31/497; A61K31/5377; A61P25/00; A61P29/00; A61P37/02; A61P43/00; C07D401/04; C07D401/12; C07D403/10; C07D403/12; C07D405/12
Domestic Patent References:
| WO2016199943A1 | 2016-12-15 | |||
| WO2012075383A2 | 2012-06-07 | |||
| WO2015011084A1 | 2015-01-29 | |||
| WO2011054843A1 | 2011-05-12 | |||
| WO2015188073A1 | 2015-12-10 | |||
| WO2012139930A1 | 2012-10-18 | |||
| WO2006114313A1 | 2006-11-02 |
Attorney, Agent or Firm:
TAKASHIMA, Hajime et al. (JP)
Download PDF: